Q32 Bio Inc.
QTTB
$1.55
-$0.135-8.01%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -47.73M | -60.61M | -57.05M | -45.88M | -53.74M |
| Total Depreciation and Amortization | 487.00K | 491.00K | 492.00K | 495.00K | 499.00K |
| Total Amortization of Deferred Charges | 194.00K | 175.00K | 132.00K | 91.00K | 87.00K |
| Total Other Non-Cash Items | -11.03M | -10.78M | -5.27M | -7.46M | 8.17M |
| Change in Net Operating Assets | -9.64M | 3.73M | 30.12M | 32.02M | 26.32M |
| Cash from Operations | -67.72M | -67.00M | -31.58M | -20.73M | -18.68M |
| Capital Expenditure | -75.00K | -73.00K | -16.00K | 0.00 | -5.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 20.00M | 20.00M | 10.00M | 97.00K | -- |
| Cash from Investing | 19.93M | 19.93M | 9.98M | 97.00K | -5.00K |
| Total Debt Issued | 7.00M | 60.16M | 65.66M | 65.66M | 5.50M |
| Total Debt Repaid | 0.00 | -8.71M | -13.91M | -8.01M | -5.20M |
| Issuance of Common Stock | 43.69M | 43.45M | 42.46M | 42.09M | 106.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 44.44M | -- | -- | -- | -- |
| Cash from Financing | 95.14M | 94.90M | 94.20M | 99.74M | 406.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 47.35M | 47.82M | 72.61M | 79.10M | -18.28M |